Design Therapeutics
DSGN
DSGN
50 hedge funds and large institutions have $546M invested in Design Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
28% less capital invested
Capital invested by funds: $755M → $546M (-$209M)
Holders
50
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$21.5M | |
| 2 | +$12.2M | |
| 3 | +$5.87M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.28M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.74M |
Top Sellers
| 1 | -$7.57M | |
| 2 | -$4.72M | |
| 3 | -$3.98M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.08M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.5M |